Abadie; Claire

Patent Applications and Registrations

Patent applications and USPTO patent grants for Abadie; Claire.The latest application filed is for "use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases".

Company Profile

0.6.6

Abadie; Claire - Annecy FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases Grant 10,967,038 - Combette , et al. April 6, 2	2021-04-06
Use Of Cell-permeable Peptide Inhibitors Of The Jnk Signal Transduction Pathway For The Treatment Of Chronic Or Non-chronic Inflammatory Eye Diseases App 20190060392 - Combette; Jean-Marc ; et al.	2019-02-28
Protein SLURP-1 for use in the treatment of ocular diseases Grant 10,098,925 - Combette , et al. October 16, 2	2018-10-16
Use Of Cell-permeable Peptide Inhibitors Of The Jnk Signal Transduction Pathway For The Treatment Of Chronic Or Non-chronic Inflammatory Eye Diseases App 20160089413 - COMBETTE; JEAN-MARC ; et al.	2016-03-31
Protein Slurp-1 For Use In The Treatment Of Ocular Diseases App 20150320831 - COMBETTE; Jean-Marc ; et al.	2015-11-12
Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases Grant 9,150,618 - Combette , et al. October 6, 2	2015-10-06
Antigen binding fragments of an antibody for use in treating or diagnosing ocular diseases Grant 8,747,856 - Abadie , et al. June 10, 2	2014-06-10
Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases App 20130337557 - Combette; Jean-Marc ; et al.	2013-12-19
Antigen Binding Fragments of an Antibody for Use in Treating or Diagnosing Ocular Diseases App 20120165512 - Abadie; Claire ; et al.	2012-06-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.